Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,033
datasets available to search
ShareScore release 0.9.0
Dataset results
1,033 results for “Embolism”
Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms
ClinicalTrials.gov study NCT07022249. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Pulmonary Embolism Registry
ClinicalTrials.gov study NCT05391646. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy of Uterine Artery Embolization (UAE) in Management of Symptomatic Uterine Adenomyosis
ClinicalTrials.gov study NCT06652945. IPD Sharing: YES. Countries: 0. Publications: 0.
Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism
ClinicalTrials.gov study NCT05821426. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders
ClinicalTrials.gov study NCT06537141. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dual-Targeted Microspheres Reshape the Metabolic-immune Microenvironment and Reverse Multiple Dilemmas Post-embolization in Hepatocellular Carcinoma_GM VS GZM
GEO Series GSE317123. Rattus norvegicus. 6 samples. Type: Expression profiling by high throughput sequencing.
Dual-Targeted Microspheres Reshape the Metabolic-immune Microenvironment and Reverse Multiple Dilemmas Post-embolization in Hepatocellular Carcinoma_HCC VS TAE
GEO Series GSE317124. Rattus norvegicus. 6 samples. Type: Expression profiling by high throughput sequencing.
A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries
ClinicalTrials.gov study NCT01101347. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Potential Targets of Cholesterol Crystal Embolism
GEO Series GSE298484. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Dataset related to article "Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization"
<p>This record contains raw data related to article "Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization"</p><p> <strong>Abstract</strong></p><p>Alterations in nutritional status, in particular sarcopenia, have been extensively associated with a poor prognosis in cirrhotic patients regardless of the etiology of liver disease. Less is known about the predictive value of myosteatosis, defined as pathological fat infiltration into the skeletal muscle. We retrospectively analyzed a cohort of 151 cirrhotic patients with unresectable hepatocellular carcinoma (HCC) who underwent their first trans-arterial embolization (TAE) between 1 March 2011 and 1 July 2019 at our Institution. Clinical and biochemical data were collected. Sarcopenia was assessed using the L3-SMI method while myosteatosis with a dedicated segmentation suite (3D Slicer), using a single slice at an axial plane located at L3 and calculating the IMAC (Intramuscular Adipose Tissue Content Index). The sex-specific cut-off values for defining myosteatosis were IMAC > −0.44 in males and >−0.31 in females. In our cohort, 115 (76%) patients were included in the myosteatosis group; 128 (85%) patients had a coexistent diagnosis of sarcopenia. Patients with myosteatosis were significantly older and showed higher BMI than patients without myosteatosis. In addition, male gender and alcoholic- or metabolic-related cirrhosis were most represented in the myosteatosis group. Myosteatosis was not associated with a different HCC burden, length of hospitalization, complication rate, and readmission in the first 30 days after discharge. Overall survival was not influenced by the presence of myosteatosis</p>
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement
<p>Dataset from the article Latib A, Mangieri A, Vezzulli P, Spagnolo P, Sardanelli F, Fellegara G, Pagnesi M, Giannini F, Falini A, Gorla R, Montorfano M, Bedogni F, Colombo A, Popma J, Merhi WM, De Marco F. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 Apr 13;13(7):860-868. doi: 10.1016/j.jcin.2019.11.017. PMID: 32273098.</p> <p><strong>Abstract</strong></p> <p><strong>Objectives: </strong>This study sought to evaluate the feasibility of complete cerebral protection during transcatheter aortic valve replacement (TAVR) with a novel embolic protection device.</p> <p><strong>Background: </strong>Evidences and data about new cerebral embolic protection devices are lacking and scarce.</p> <p><strong>Methods: </strong>A prospective, nonrandomized, multicenter, first-in-man pilot study designed to evaluate the efficacy and safety of cerebral embolic protection utilizing the Emblok embolic protection system (Innovative Cardiovascular Solutions, Grand Rapids, Michigan) during TAVR. The Emblok is a transfemoral aortic filter that provide full coverage of the epiaortic vessels. Brain diffusion-weighted magnetic resonance imaging (DW-MRI) was performed at baseline and 2 to 5 days after TAVR. Primary endpoints were technical success and immediate cerebral embolic burden after TAVR, defined as number and volume of new brain lesions detected with DW-MRI at days 2 to 5 post-TAVR compared with baseline.</p> <p><strong>Results: </strong>A total of 20 subjects were enrolled. The Emblok system was successfully positioned in all the cases. At 30-day follow-up, no major adverse cardiovascular and cerebrovascular events occurred. Nineteen (95%) patients had new ischemic defects at post-procedural DW-MRI. The median number of new lesions per patient was 10.00 (interquartile range [IQR]: 4.75 to 15.25). The total new lesion volume was 199.9 mm<sup>3</sup> (IQR: 83.9 to 447.5 mm<sup>3</sup>) and the mean lesion volume per lesion was 42.5 mm<sup>3</sup> (IQR: 21.5 to 75.6 mm<sup>3</sup>). Histopathologic analysis showed evidence of significant debris in 18 (90%) filters.</p> <p><strong>Conclusions: </strong>The Emblok embolic protection system appears to be feasible and safe during TAVR. The device was successfully placed and retrieved in all cases and no neurological events were observed. Cerebral total new lesion volume was similar to other trials on cerebral protection during TAVR, thus warranting a larger study. (European Study Evaluating the Emblok Embolic Protection System During TAVR.</p>
Real-time MRI monitoring of liquid embolic agent (Onyx) injection in a swine arteriovenous malformation model.
<p><br> </p> <p><strong>Movie 1 Real-time, dynamic EPI-GRE T2 scan of the whole brain volume during Onyx injection. Cine sequence of the ONYX propagation at the level of the pons. Dark liquid embolic agent is gradually filling small arteries around the pons. </strong></p> <p> </p> <p><strong>Movie 2 Real-time dynamic EPI-GRE MRI monitoring of the test infusion of diluted gadolinium (10mM) seen as a short wash-in and wash-out of hypointense signal, confirming the proper position of the microcatheter and verifying the area of trans-catheter perfusion.</strong></p>
An image dataset for estimation of nuclei density of lobules related to Cell atlas of the regenerating human liver after portal vein embolization
<p>Dataset of Tissue samples for cell atlas</p> <p>datafilename coding:<br>first Character: sex of patient ( B- men, K- women) <br>second char: condition (0- conroll, 1- embolized, 2- regenerated)<br>next chars to Letter: Date of Dataset<br>Letter char with number: Lobule of Marker Charge( G- GLUL)</p> <p>Tiff: fiji proceed images<br>zip: coordinates for fiji<br>csv: cleaned and readable format of coordinates for python<br>PNG: Hoechst marked Nuclei of GLUL marker</p> <p> </p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.